124 related articles for article (PubMed ID: 26439471)
21. C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease.
van Durme YM; Verhamme KM; Aarnoudse AJ; Van Pottelberge GR; Hofman A; Witteman JC; Joos GF; Brusselle GG; Stricker BH
Am J Respir Crit Care Med; 2009 Mar; 179(5):375-82. PubMed ID: 19096002
[TBL] [Abstract][Full Text] [Related]
22. Single-nucleotide polymorphisms in the TSPYL-4 and NT5DC1 genes are associated with susceptibility to chronic obstructive pulmonary disease.
Guo Y; Gong Y; Shi G; Yang K; Pan C; Li M; Li Q; Cheng Q; Dai R; Fan L; Wan H
Mol Med Rep; 2012 Sep; 6(3):631-8. PubMed ID: 22736055
[TBL] [Abstract][Full Text] [Related]
23. The role of MMP-12 gene polymorphism - 82 A-to-G (rs2276109) in immunopathology of COPD in polish patients: a case control study.
Gilowska I; Majorczyk E; Kasper Ł; Bogacz K; Szczegielniak J; Kasper M; Kaczmarski J; Skomudek A; Czerwinski M; Sładek K
BMC Med Genet; 2019 Jan; 20(1):19. PubMed ID: 30658596
[TBL] [Abstract][Full Text] [Related]
24. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function.
Joos L; He JQ; Shepherdson MB; Connett JE; Anthonisen NR; Paré PD; Sandford AJ
Hum Mol Genet; 2002 Mar; 11(5):569-76. PubMed ID: 11875051
[TBL] [Abstract][Full Text] [Related]
25. Periodontal health and serum, saliva matrix metalloproteinases in patients with mild chronic obstructive pulmonary disease.
Yıldırım E; Kormi I; Başoğlu ÖK; Gürgün A; Kaval B; Sorsa T; Buduneli N
J Periodontal Res; 2013 Jun; 48(3):269-75. PubMed ID: 22967248
[TBL] [Abstract][Full Text] [Related]
26. [Study on matrix metalloproteinase 1, 9, 12 polymorphisms and susceptibility to chronic obstructive pulmonary disease among Han nationality in northern China].
Zhang RB; He QY; Yang RH; Lu BB; Liu YJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Nov; 26(11):907-10. PubMed ID: 16676616
[TBL] [Abstract][Full Text] [Related]
27. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
[TBL] [Abstract][Full Text] [Related]
28. Association of IL-6 gene polymorphisms and COPD in a Spanish population.
Córdoba-Lanús E; de-Torres JP; López-Aguilar C; Rodríguez-Pérez MC; Maca-Meyer N; Montejo-de-Garcini A; Aguirre-Jaime A; Pérez-Méndez L; Casanova C
Respir Med; 2008 Dec; 102(12):1805-11. PubMed ID: 18693004
[TBL] [Abstract][Full Text] [Related]
29. Impact of cathepsin D activity and C224T polymorphism (rs17571) on chronic obstructive pulmonary disease: correlations with oxidative and inflammatory markers.
Bchir S; Boumiza S; Ben Nasr H; Garrouch A; Kallel I; Tabka Z; Chahed K
Clin Exp Med; 2021 Aug; 21(3):457-465. PubMed ID: 33611777
[TBL] [Abstract][Full Text] [Related]
30. [Association of the MMP3, MMP9, ADAM33 and TIMP3 genes polymorphic markers with development and progression of chronic obstructive pulmonary disease].
Korytina GF; Tselousova OS; Akhmadishina LZ; Victorova EV; Zagidullin ShZ; Victorova TV
Mol Biol (Mosk); 2012; 46(3):487-99. PubMed ID: 22888638
[TBL] [Abstract][Full Text] [Related]
31. [Study on the correlation of interleukin-13 polymorphism and susceptibility to chronic obstructive pulmonary disease in Chinese Han population].
Hu RC; Xu YJ; Zhang ZX
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):607-11. PubMed ID: 15308043
[TBL] [Abstract][Full Text] [Related]
32. IL-8 gene variants are associated with lung function decline and multidimensional BODE index in COPD patients but not with disease susceptibility: a validation study.
Córdoba-Lanús E; Baz-Dávila R; Espinoza-Jiménez A; Rodríguez-Pérez MC; Varo N; de-Torres JP; González-Almeida D; Aguirre-Jaime A; Casanova C
COPD; 2015 Feb; 12(1):55-61. PubMed ID: 24946112
[TBL] [Abstract][Full Text] [Related]
33. Association of genetic dependences between lung cancer and chronic obstructive pulmonary disease.
Grudny J; Kołakowski J; Kruszewski M; Szopiński J; Sliwiński P; Wiatr E; Winek J; Załęska J; Zych J; Roszkowski-Śliż K
Pneumonol Alergol Pol; 2013; 81(4):308-18. PubMed ID: 23744166
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.
Wieczorek E; Reszka E; Jablonowski Z; Jablonska E; Krol MB; Grzegorczyk A; Gromadzinska J; Sosnowski M; Wasowicz W
BJU Int; 2013 Dec; 112(8):1207-14. PubMed ID: 23819551
[TBL] [Abstract][Full Text] [Related]
35. [Association of cytochrome P450 genes polymorphisms (CYP1A1 and CYP1A2) with the development of chronic obstructive pulmonary disease in Bashkortostan].
Korytina GF; Akhmadishina LZ; Kochetova OV; Zagidullin ShZ; Viktorova TV
Mol Biol (Mosk); 2008; 42(1):32-41. PubMed ID: 18389617
[TBL] [Abstract][Full Text] [Related]
36. Impact of CYP1A1 Polymorphisms on Susceptibility to Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
Wang CD; Chen N; Huang L; Wang JR; Chen ZY; Jiang YM; He YZ; Ji YL
Biomed Res Int; 2015; 2015():942958. PubMed ID: 26425562
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
38. Association of the CAT-262C>T polymorphism with asthma in smokers and the nonemphysematous phenotype of chronic obstructive pulmonary disease.
Taniguchi N; Konno S; Isada A; Hattori T; Kimura H; Shimizu K; Maeda Y; Makita H; Hizawa N; Nishimura M
Ann Allergy Asthma Immunol; 2014 Jul; 113(1):31-36.e2. PubMed ID: 24824229
[TBL] [Abstract][Full Text] [Related]
39. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
[TBL] [Abstract][Full Text] [Related]
40. Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.
Haq I; Chappell S; Johnson SR; Lotya J; Daly L; Morgan K; Guetta-Baranes T; Roca J; Rabinovich R; Millar AB; Donnelly SC; Keatings V; MacNee W; Stolk J; Hiemstra PS; Miniati M; Monti S; O'Connor CM; Kalsheker N
BMC Med Genet; 2010 Jan; 11():7. PubMed ID: 20078883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
